This Agreement dated DD/MM/YYYY (the Effective Date ) is between
|
|
- Leonard Cummings
- 6 years ago
- Views:
Transcription
1 Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7 2UH, UK(hereinafter referred to as the Sponsor ) AND The Nottingham Clinical Trials Unit, University of Nottingham (hereinafter referred to as the NCTU ) AND CI s Name, of Department, Address, (hereinafter referred to as the Chief ) WHEREAS for the conduct of the Clinical Trial entitled Insert Study Title ( the Clinical Trial ) NUH R&D Ref number: EudraCT number: (A) The Sponsor has agreed to take the responsibilities of Sponsor as defined by the Medicines for Human Use (Clinical Trials) Regulations (B) The Sponsor delegates responsibility for the management of the Clinical Trial to NCTU. (C) Chief has sufficient knowledge and experience to conduct this Clinical Trial. (D) The purpose of the Agreement is to provide for the proper management and governance of the Clinical Trial and to set out the respective roles and responsibilities that the Sponsor wishes to delegate to the Chief and/or subcontractors. 1. The Agreement shall commence on the Effective Date and shall remain in force until the trial end date. 2. The Chief and the NCTU shall undertake the responsibilities delegated by the Sponsor as set out below. 3. Where the Chief wishes to delegate responsibilities to another member of the Trial team, that individual must receive sufficient support and training to fulfil that role and all delegated duties must be detailed within the Trial Master File. Page 1 of 10
2 1 Sponsorship Undertake role of Sponsor as defined by the Medicines for Human Use (Clinical Trials) Regulations 2004, as amended. Responsibility for the liability and indemnity for the trial as defined under UK regulations. Appoint an individual to represent the sponsor s interests for the duration of the trial on the Trial Steering Committee 2 Trial Documentation ( inc Trial Master File (TMF), protocol, CRFs, PIS) Design the research protocol describing the objectives, design, methodology, statistical considerations and organisation of the trial Keep a TMF for the clinical trial containing the essential documents relating to the clinical trial Ensure that the TMF (and other appropriate trial files) is readily available at all reasonable times for inspection by the licensing authority or any person appointed by the Sponsor to audit the arrangements for the trial Prepare documentation to assist with the organisation, management and conduct of the trial. This documentation includes but is not limited to, participant information sheets, consent forms, case report forms, participant diaries, SOPs etc. Keep a TMF for the clinical trial containing the essential documents relating to the clinical trial Verify that the TMF contains all essential documents ( via a Trial Initiation Visit) prior to Trial commencement Ensure that the TMF (and other appropriate trial files) is readily available at all reasonable times for inspection by the licensing authority or any person appointed by the Sponsor to audit the arrangements for the trial 3 Permissions and notifications Ensure amendments to the CTA have been approved by (a) REC; and (b) MHRA Prior to implementation Application for the main Research Ethics Committee (REC) opinion. Request for authorisation to conduct a clinical trial made to the licensing authority ( MHRA.). Notify MHRA and the Sponsor of amendments to the CTA which includes an amendment to (a) The terms of the request for authorisation of the clinical trial; or (b) The particulars or documents that accompanied that request Application for the main Research Ethics Committee (REC) opinion. Request for authorisation to conduct a clinical trial made to the licensing authority (MHRA.). Notify MHRA and the Sponsor of amendments to the CTA which includes an amendment to (a) The terms of the request for authorisation of the clinical trial; or (b) The particulars or documents that accompanied that request Page 2 of 10
3 4 Trial Management Notify the REC and the Sponsor of amendments to the favourable opinion which includes an amendment to (a) The terms of the application for REC opinion; or (b) The particulars or documents that accompanied that application Notify MHRA, REC and the Sponsor that the trial has ended within 90 days of the conclusion of the trial Notify MHRA, REC and Sponsor within 15 days if the trial is terminated (a) Before the date for the conclusion of the trial specified in the protocol, or (b) Before the event specified in the protocol as the event which indicates the end of the trial has occurred.. Notify MHRA and Sponsor in writing of any serious breach of (a) the conditions and principles of GCP in connection with the trial (b) the protocol relating to the trial Immediately after becoming aware of that breach Provide the REC and the Sponsor with an annual progress report Ensure Site Registration process as described in the Protocol is complete before Trial commences at each Site. Notify the REC and the Sponsor of amendments to the favourable opinion which includes an amendment to (a) The terms of the application for REC opinion; or (b) The particulars or documents that accompanied that application Notify MHRA, REC and the Sponsor that the trial has ended within 90 days of the conclusion of the trial Notify MHRA, REC and Sponsor within 15 days if the trial is terminated (c) Before the date for the conclusion of the trial specified in the protocol, or (d) Before the event specified in the protocol as the event which indicates the end of the trial has occurred. Notify MHRA and Sponsor in writing of any serious breach of (a) the conditions and principles of GCP in connection with the trial (b) the protocol relating to the trial within 7 days of becoming aware of that breach Provide the REC and the Sponsor with an annual progress report Ensure Site Registration process as described in the Protocol is complete before Trial commences at each Site. Appoint and coordinate a trial management group (TMG) to consider day-to-day management issues and the overall progress of the trial Convene a trial steering committee to provide oversight of the trial. Convene an independent data monitoring committee (IDMC) to receive and review the progress and accruing data of the trial and provide advice on the conduct of the trial to TSC. 5 Contracts Page 3 of 10
4 Use the UKCRC mnca agreement and supporting documents as the suite of documents forming the agreements between NUH and collaborating NHS sites Ensuring that appropriate written agreements are in place between the Sponsor and any organizations carrying out duties on a subcontractual basis (including IMP supply agreements) 6 Conduct of the Trial Review Sponsor registration form, finalised protocol and participant information prior to REC submission 7 IT/Data Provide input into the negotiation of the contracts Ensure the conduct of Trial is in accordance with GCP and applicable Regulations Verify that The Trial Master File has all essential documents in place prior to Trial commencement Ensure the conduct of trial is in accordance with (a) the protocol (b) the terms of (i) the CTA (ii) REC approval Receive, read and follow all relevant central SOPs. Prepare standard operating procedures (SOPs) identified as necessary to manage the trial Ensure all researchers involved and participating sites and staff are aware of, trained in and complying with trial specific SOPs, via trial initiation meeting if appropriate Inform the participating site and the site principal investigator of the name and telephone number of the trial manager and the sponsor s representative. Implement adequate business continuity / disaster recovery plans to ensure recovery and restoration of critical trial functions following unforeseen disasters or extended disruption Ensuring regulatory compliant randomisation and/or registration into trials Ensure the conduct of Trial is in accordance with GCP and applicable Regulations Verify that The Trial Master File has all essential documents in place prior to Trial commencement Ensure the conduct of trial is in accordance with (a) the protocol (b) the terms of (i) the CTA (ii) REC approval Maintain central SOPs and make them available to CI Review and approve relevant Trial SOPs Ensure all researchers involved and participating sites and staff are aware of, trained in and complying with trial specific SOPs, via trial initiation meeting if appropriate Inform the participating site and the site principal investigator of the name and telephone number of the trial manager and the sponsor s representative. Implement adequate business continuity / disaster recovery plans to ensure recovery and restoration of critical trial functions following unforeseen disasters or extended disruption Ensure IT systems and processes are set up to ensure data integrity and archiving to adequate regulatory requirements including but not limited to database set up and hosting and IT security Page 4 of 10
5 Take on the role of Data Custodian and Systems Manager 8 Pharmacovigilance Make appropriate urgent safety measures in order to protect the participants of a clinical trial against any immediate hazards to their health or safety Make appropriate urgent safety measures in order to protect the participants of a clinical trial against any immediate hazards to their health or safety Assessment of SAEs Ensure that the Principal s responsible for the conduct of a trial are informed of any SUSAR which occurs in relation to an IMP used in that trial Make appropriate urgent safety measures in order to protect the participants of a clinical trial against any immediate hazards to their health or safety Report Urgent Safety measures to Sponsor, MHRA and REC Keep detailed records of all adverse events which are reported by the investigators for that trial. Ensure that SUSARs are (a) recorded; and (b) reported as soon as possible (i) the licensing (ii) authority, the relevant ethics committee, (iii) the Sponsor and in any event not later than 7 days (fatal or life threatening) or 15 days (nonfatal or life threatening) after the first awareness of the reaction Ensure that within 8 days of a report any additional information is sent to the licensing authority and the relevant ethics committee As soon as practicable after the end of the reporting year provide the licensing authority, the relevant ethics committee and Sponsor with (a) a list of all SUSARs which have occurred during that year, including those reactions relating to any IMP used as a placebo or as a reference in those trials a report on the safety of the participants of those trials a report on the safety of the participants of those trials As soon as practical after the end of the reporting year provide Principal s at each of the sites a line listing of all suspected serious adverse reactions which have occurred during that year Page 5 of 10
6 9 Monitoring 10 Archiving 11 Quality Assurance 12 Reporting and Finance Carry out central and site monitoring. Ensure that all documents contained, or have been contained, in the Sponsor TMF are retained for at least 5 years after the conclusion of the trial Appoint named individuals to be responsible for archiving the documents which are or have been contained in the TMF and, with the exception of the licensing authority and any person appointed by the Sponsor to audit the arrangements for the trial, access to those documents shall be restricted to those appointed individuals Ensure secure restricted access (to delegated individuals) archiving space that meets regulatory requirements Implement and maintain quality assurance and quality control systems with written SOPs to ensure that the research is conducted and data generated, documented and reported in compliance with the protocol, GCP and applicable regulatory requirements Ensure reporting to relevant groups including but not limited to the funders as per their requirements. Ensure grant funds are administered in accordance with the terms of the award, properly recorded and reported, and that requests to funders for renewal or re-allocation are made promptly 13 Statistics analysis and publication Ensuring regulatory and GCP compliant statistical arrangement including but not limited to design, statistical analysis and appropriate documentation Responsibility for producing the trial publication Page 6 of 10
7 Holder of any intellectual property including power to delegate decision for data release. 14 Drug and its movement Ensuring confidentiality to a level dictated by regulatory requirement or imposed by sponsor and/or funder Ensuring publication is sent for review to appropriate parties including but not limited to any party to whom the Sponsor has any legal obligations to give notice of publication Ensuring confidentiality to a level dictated by regulatory requirement or imposed by sponsor and/or funder Ensuring regulatory and GCP compliant data management including but not limited to CRF movement, databases and data handling and following up data queries. Ensure the investigator s brochure/smpc (if available) is valid and updated at least once a year Provide site principal investigators with (or link to) updated investigator s brochure/ SmPC (if available) as necessary Ensuring a regulatory compliant IMP handling/custody including but not limited to adequate QP release, documentation to ensure quality and certificate of analysis Central IMP accountability, ordering and distribution The undersigned confirm their acceptance of the terms of this Agreement For and on behalf of the Sponsor Name : Dr Maria Koufali Title : Asst. Director of Research & Innovation The Chief Name :.. Title :.. Signature Signature For and on behalf of the Nottingham Clinical Trials Unit Name : Title : Page 7 of 10
8 Signature Page 8 of 10
9 Schedule A Financial Arrangements The fees detailed below are the costs incurred by NUH as sponsor and each Party understands and accepts that payment of these fees is to be made in accordance with the following payment schedule: [DELETE AS APPROPRIATE] Non CTIMP Studies Payable upon receipt of R&D Approval Payable upon receipt of R&D Approval at Additional Sites Single Site (NUH Only) 1,500 Multiple Sites 1, per site The Payments detailed above are to be made in consideration of the following activities carried out by the Sponsor: Contract management including sub-contracts where necessary, financial oversight and funder reports Advice/Support (24/7, 365 days a year) Trial Registration Externally accessible server space for hosting web applications (websites, document repositories) Patient and Public Involvement (PPI) Advice and support [DELETE AS APPROPRIATE] CTIMP and Medical Device Studies Payable upon receipt of R&D Approval Annual Payments for each completed year Annual Payments for each completed year per additional site Single Site (NUH Only) 5,000 2,000 Multiple Sites 5,000 2,000 Annual payments shall be calculated on a pro rata basis where trial duration is less than 12 months or where a trial is subject to early termination. The payments detailed above are to be made in consideration of the following activities carried out by the Sponsor: Trial registration Externally accessible server space for hosting web applications (websites, document repositories) Patient and Public Involvement (PPI) including advice and support Monitoring including development of monitoring plans, site visits (and associated travel costs), attendance at data monitoring committees SOP compliance audits Contract management including sub-contracts where relevant, financial oversight and funder reports Site set-up site files, delegation logs etc Pharmacovigilance including safety reporting Contribution to Sponsor overheads including MHRA GCP inspection fees, environmental monitoring equipment Page 9 of 10
10 Archiving by a certified archivist in secure facilities for 15 years following study closure Support/advice with regulatory approvals including completion of forms (MHRA, REC) Training of study staff (e.g. GCP, pharmacovigilance, SOP s) Advice/Support (24/7, 365 days a year) Invoices to be submitted to: [INSERT DETAILS OF FUNDER WHERE NECESSARY] Payments to be made in accordance with the following Payee Name GBS Re Nottm Uni Hospital NHST Bank Account Number Sort Code IBAN GB69CITI BIC CITIGB2L Bank Name Citi Bank Bank Address Government Banking Service C/O Citi Bank, Citi Group Centre, 25 Canada Square, Canary Wharf, London E14 5LB Vat/Tax At current applicable rate VAT/Tax Details Address of Payee Nottingham University Hospitals NHS Trust, P.O. Box 5711, Finance Department, City Hospital Campus, Hucknall Road, Nottingham NG5 1PT Remittance Information /Company/R&D Ref No. Nottingham University Hospitals NHS Trust, P. O. Box 5711, Finance Department, City Hospital Campus, Hucknall Road, Nottingham NG5 1PT Or Cashiers@nuh.nhs.uk Page 10 of 10
STANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number End of Study Report SOP-RES-027 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Natalie
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationSOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227
SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationGovernance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise
Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationM. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance and Safety Reporting for Sponsored non-ctimps SOP Number: 26b Version 2.0 Number: Effective Date: 29th November 2015 Review Date: 3 rd December
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationMarie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance processing for the JRMO SOP Number: 26c Version Number: V1 Effective Date: 5/8/16 Review Date: 5/8/17 Author: Reviewer: Reviewer: Authorisation:
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)
More information1. INTRODUCTION 2. SCOPE 3. PROCESS
1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of
More informationSTANDARD OPERATING PROCEDURE SOP 205
STANDARD OPERATING PROCEDURE SOP 205 Adverse Events: Identifying, Recording and Reporting for CTIMPs Sponsored by the Norfolk and Norwich University Hospital NHS Foundation Trust Version 2.3 Version date
More informationDocument Title: Investigator Site File. Document Number: 019
Document Title: Investigator Site File Document Number: 019 Version: 1.1 Ratified by: R&D Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationCorporate. Research Governance Policy. Document Control Summary
Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:
More informationR. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: BH/QMUL Sponsorship of CTIMPs, ATMPs and Clinical Trials of non- CE marked Medicinal Devices Process for Researchers SOP Number: 11a Version Number: V1.0 Effective
More informationResearch & Development Quality Manual
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager Version: 3 Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Document History
More informationJoint R&D Support Office SOP S-2011 UHL
UNIVERSITY OF LEICESTER & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES Joint R&D Support Office SOP S-2011 UHL Site Initiation for
More informationStandard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research
Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document
More informationDetails: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure
Details: Author: Razwan Mahroof - QA Clinical Trials Monitor SOP Pages: 10 Version No. of replaced SOP: 1.0 Effective date of replaced SOP: 04 December 2015 Approval: Version No: of the SOP being approved.
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Adverse Event Identification, Recording and Reporting in Clinical Trials of Investigational Medicinal SOP-RES-019 Version Number 2 Issue Date 08 th Dec
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Risk Assessment SOP-RES-002 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s)
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More informationSOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationSTANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice
STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationDocument Title: Study Data SOP (CRFs and Source Data)
Document Title: Study Data SOP (CRFs and Source Data) Document Number: SOP047 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationResearch Staff Training
REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationStorage and Archiving of Research Documents SOP 6
Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager
More informationRisk Assessment and Monitoring
Version 1.3 Effective date: 25 May 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.3 25 May 2012 Version 1.2 29 January 2010
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationResearch Adverse Event and Safety Reporting Procedures Outcome Statement: Title:
Title: Research Adverse Event and Safety Reporting Procedures Outcome Statement: Research Teams will be able to correctly identify and report Adverse Events and complete Annual Safety Reports for research
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationStandard Operating Procedure:
Standard Operating Procedure: Preparation and Submission of Annual Progress Reports for all Research Projects and Development Safety Update Reports SOP Number: SOP-QA-21 Version No: 1 Author: Date: 1-9-15
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical
More informationMANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic
More informationOnce the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationEuropean Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS
European Medicines Agency Inspections London, 23 July 2008 EMEA/INS/GCP/197215/2005 Procedure no.: INS/GCP/3/V ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS GCP
More informationABMU R&D Operational Framework
ABMU R&D Operational Framework 2017 ABMU R&D Operational Framework 1 R&D Operational Arrangements University Partnership As a University Health Board, ABMU has signed a Memorandum of Understanding (MOU)
More informationReference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015
Reference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015 Safety Reporting in CTIMPs Standard Operating Procedure Introduction and Aim The
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Corrective and Preventative Action SOP-QMS-008 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s)
More informationPOLICY ON RESEARCH RELATED ADVERSE EVENT REPORTING
POLICY ON RESEARCH RELATED ADVERSE EVENT REPORTING CLASSIFICATION TRUST POLICY NUMBER APPROVING COMMITTEE R & D Governance Committee RATIFYING COMMITTEE Quality & Risk Committee DATE RATIFIED October 2009
More informationSTH Researcher. Recording of research information in patient case notes
STANDARD OPERATING PROCEDURE STH Researcher Recording of research information in patient case notes SOP History None SOP Number A108 Created Research Department (AL) SUPERSEDED Final 1.3 Version 3.5 Date
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationMarie-Claire Rickard, Governance and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of or the Trial Protocol SOP Number: 037 Version Number: 5.0 Effective Date: 17/6/16 Review Date: 17/6/18 Author: Reviewer: Reviewer
More informationI2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator
I2S2 TRAINING Good Clinical Practice tips Deirdre Thom Neonatal Nurse Coordinator Content Principal investigator (slides 3-5) Delegation and delegation log (slides 6-7) Informed consent (slides 8-15) Data
More informationGCP INSPECTORATE GCP INSPECTIONS METRICS REPORT
GCP INSPECTORATE GCP INSPECTIONS METRICS REPORT METRICS PERIOD: 1 st April 1 to 31 st March 11 DATE OF ISSUE: 1 th March 1 MHRA Central Region Medicines Inspectorate Falcon Way, Shire Park Welwyn Garden
More informationPreparation for an MHRA GCP Inspection including Training on New and Up-dated SOPs
Preparation for an MHRA GCP Inspection including Training on New and Up-dated SOPs 2015 Medicines and Healthcare products Regulatory Agency NHS Grampian & University of Aberdeen MHRA GCP Inspection 2015
More informationRisk Assessment. Version Number 1.0 Effective Date: 21 st March Sponsored Research
Risk Assessment Sponsored Research SOP Reference ID: Noclor/Spon/S03/01 Version Number 1.0 Effective Date: 21 st March 2016 It is the responsibility of all users of this SOP to ensure that the correct
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally
More informationJoint Statement on the Application of Good Clinical Practice to Training for Researchers
Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement
More informationDocument Title: Version Control of Study Documents. Document Number: 023
Document Title: Version Control of Study Documents Document Number: 023 Version: 1.1 Ratified by: Committee Date ratified: 03 OCT 2017 Name of originator/author: Directorate: Department: Name of responsible
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationStudy Monitoring Plan Template
Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &
More informationIDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES
IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES DOCUMENT NO.: CR012 v2.0 AUTHOR: Raymond French ISSUE DATE: 18 September 2017 EFFECTIVE DATE: 02 October
More informationSOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection
SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne
More informationDocument Title: File Notes. Document Number: 024
Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel
More informationRESEARCH GOVERNANCE GUIDELINES
RESEARCH GOVERNANCE GUIDELINES STUDY STEERING COMMITTEE (SSC) or TRIAL STEERING COMMITTEE (TSC) This document is designed to provide information and guidance relating to Steering Committees and Data Monitoring
More informationThis is a full time post offered on a fixed-term basis until 31 August 2019.
Faculty of Medicine and Health Sciences Norwich Medical School CTU Trial Assistant REF: SC3019 This is a full time post offered on a fixed-term basis until 31 August 2019. The Post A Clinical Trial Assistant
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording, Managing and Reporting Adverse Events SOP Number: 2 Version Number: 3.0 Supersedes: 2.1 Effective date: May 2013
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationSOP19a & 19b: Standard Operating Procedure for (a) Safety Monitoring (especially Pharmacovigilance) & (b) Urgent Safety Measures
SOP19a & 19b: Standard Operating Procedure for (a) Safety Monitoring (especially Pharmacovigilance) & (b) Urgent Safety Measures Authorship Team: Anne Seagrove, Melanie Storey, Ian Russell for Joint SOP
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Risk Assessment of NCTU Studies SOP number: TM-020 SOP category: Trial Management Version number: 02 Version date: 16
More informationGaining NHS Trust R&D Approvals
Version 1.1 Effective date: 1 October 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Reason for change Version 1.1 1 October 2012
More informationDocument Title: Informed Consent for Research Studies
Document Title: Informed Consent for Research Studies Document Number: SOP003 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH THE START UP PROCEDURE FOR RESEARCH STUDIES
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationSOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils
Title: Assessment of Study Feasibility Manual: RI MUHC Policies and Procedures Human Research SOPs Originating Dept/ Service: RI MUHC Division of Clinical Research SOP: New Revised Reviewed Effective Date:
More informationETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM
ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM Outline Introduction Composition Responsibilities of IEC Responsibilities
More informationAdvanced Professional Module Clinical Research (2016) Approved by GMC on 14 July 2016 and launched September 2016
Advanced Professional Module Clinical Research (2016) Approved by GMC on 14 July 2016 and launched September 2016 Anchor Statement To define the skills that a Consultant Obstetrician/ Gynaecologist requires,
More information